THE PATHOGENETIC BASIS FOR USING NATURAL PROGESTERONE THERAPY IN OBSTETRIC PRACTICE
Abstract
Progesterone is a natural female hormone. Called “the pregnancy hormone,” it is essential before and during pregnancy. After ovulation occurs, the ovaries start to produce progesterone needed by the uterus. Progesterone causes the uterine lining or endometrium to thicken. This helps prepare a supportive environment in your uterus for a fertilized egg.A supply of progesterone to the endometrium continues to be important during pregnancy. Following a successful implantation, progesterone helps maintain a supportive environment for the developing fetus.
About the Authors
V. O. Bitsadze
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation
Russian Federation
S. V. Akinshina
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation
Russian Federation
J. Kh. Khizroeva
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation
Russian Federation
N. A. Makatsariya
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation
Russian Federation
N. S. Stuleva
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation
Russian Federation
T. Ya. Mashkova
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation
Russian Federation
References
1. Baimuradova S.M. Patogenez, printsipy diagnostiki, profilaktiki i terapii sindroma poteri ploda, obuslovlennogo priobretennymi i geneticheskimi defektami gemostaza. Doct, Diss (Pathogenesis, principles of diagnosis, prevention and treatment of the syndrome of fetal loss due to genetic defects and acquired hemostasis). Dr. diss. Moscow. 2006; 291 s.
2. Belyakov N.A., Seidova G.B., Chubrieva S.Yu., Glukhov N.V. Metabolic syndrome in women (pathophysiology and clinical) [Metabolicheskii sindrom u zhenshchin (patofiziologiya i klinika)]. St. Petersburg. 2005. 440 s.
3. Bogdanova E.A., Telunts A.V. Hirsutism in girls and young women [Girsutizm u devochek i molodykh zhenshchin]. Moscow. 2002; 96 s.
4. Burchinskii S.G. Zdorov’e Ukrainy. 2004; 3.
5. Virilism. Endocrine diseases and syndromes. Edited by M.S. Biryukova [Virilizm. Endokrinnye zabolevaniya i sindromy. Pod redaktsiei M.S. Biryukovoi]. Moscow. 2000; 9-32.
6. Dmitriev A.N. Obesity and metabolic syndrome [Ozhirenie i metabolicheskii sindrom]. Ekaterinburg. 2001; 160 c.
7. Dobrokhotova Yu.E. Utrozhestan in the treatment of miscarriage [Utrozhestan v lechenii nevynashivaniya beremennosti]. Moscow. 2005; 6-13.
8. Makatsariya A.D., Beloborodova E.V., Baimuradova S.M., Bitsadze V.O. Hyperhomocysteinemia and pregnancy complications [Gipergomotsisteinemiya i oslozhneniya beremennosti]. Moscow. 2005; 147-180.
9. Makatsariya A.D., Bitsadze V.O. Thrombophilia and antithrombotic therapy in obstetric practice [Trombofilii i protivotromboticheskaya terapiya v akusherskoi praktike]. Moscow. 2003; 904 s.
10. Manukhin I.B., Gevorkyan M.A. i soavt. Problemy reproduktsii. 1999; 4: 7-13.
11. Nazarenko T.A., Durinyan E.R., Baibarina G.V. Hyperandrogenism. A practical guide [Giperandrogeniya. Prakticheskoe rukovodstvo]. M. 2004; 3-5.
12. Reznikov A.G. Praktikuyushchii vrach. 2004; 3: 5.
13. Balen A.H. et al Polycystic ovary syndrome. London and New York. 2005; 256 p.
14. Eckel Robert H. Obesity: mechanisms and clinical management. Philadelphia. 2003; 378-398.
15. Furukawa S., Fujita T., Shimabukuro M. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation. 2004; 114 (12): 1752- 1761.
16. Kruijver F.P. Zhou J.N., Pool C.W., Hofman M.A., Gooren L.J., Swaab D.F: Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J. Clin. Endocrinol. Metab. 2000; 85: 2034-2041.
17. Swaab D.F: The human hypothalamus. Basic and Clinical Aspects. Part I: Nuclei of the Hypothalamus. Handbook of Clinical Neurology; in Aminoff M.J., Boller F., Swaab D.F. (ed. Amsterdam. 2003; 79.
18. Swaab D.F., Fliers E. A sexually dimorphic nucleus in the human brain. Science. 1985; 228: 1112-1115.
19. Swaab D.F. Sexual differentiation of the human brain: Relevance for gender identity, transsexualism and sexual orientation. Gynecol. Endocrinol. 2004; 19: 301-312.
20. Swaab D.F., Hofman M.A. An enlarged suprachiasmatic nucleus in homosexual men. Brain Res. 1990; 537: 141-148.
21. Swaab D.F. The Human Hypothalamus. Basic and Clinical Aspects. Part II: Neuropathology of the hypothalamus and adjacent brain structures. Handbook of Clinical Neurology. Amsterdam. 2004.
22. Takaya J., Higashino H., Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes. Res. 2004 Jun; 17 (2): 126-36.
23. Zhou J.N., Hofman M.A., Gooren L.J., Swaab D.F. A sex difference in the human brain and its relation to transsexuality. Nature. 1995; 378: 68-70.
24.
25.
Review
For citations:
Bitsadze V.O., Akinshina S.V., Khizroeva J.K., Makatsariya N.A., Stuleva N.S., Mashkova T.Y. THE PATHOGENETIC BASIS FOR USING NATURAL PROGESTERONE THERAPY IN OBSTETRIC PRACTICE. Obstetrics, Gynecology and Reproduction. 2014;8(2):79-88. (In Russ.)
Views: 495
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
